Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Valproic Acid on Vixotrigine PK
NCT03385525Phase 1Completed
- Sponsor
- Biogen
- Start
- Sep 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vixotrigine in trigeminal neuralgia (TN), sponsored by Biogen. Primary endpoints: Maximum Observed Concentration, Area Under the Concentration-Time Curve from Time 0 to Infinity and 6 more. Started Sep 2017; status: completed.
02
Drugs
vixotrigine
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT03385525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03385525.